Ether hydrochloride → (r)-5,11-Dihydro-5-[1-[3-(4-methoxyphenyl)propyl]pyrrolidine-3-yl]dibenzo[b,e][1,4]oxazepine hydrochloride
反応式
[ClH:1].C(OCC)C.[CH3:7][O:8][C:9]1[CH:14]=[CH:13][C:12]([CH2:15][CH2:16][CH2:17][N:18]2[CH2:22][CH2:21][C@@H:20]([N:23]3[C:29]4[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=4[CH2:27][O:26][C:25]4[CH:34]=[CH:35][CH:36]=[CH:37][C:24]3=4)[CH2:19]2)=[CH:11][CH:10]=1>ClCCl>[ClH:1].[CH3:7][O:8][C:9]1[CH:10]=[CH:11][C:12]([CH2:15][CH2:16][CH2:17][N:18]2[CH2:22][CH2:21][C@@H:20]([N:23]3[C:29]4[CH:30]=[CH:31][CH:32]=[CH:33][C:28]=4[CH2:27][O:26][C:25]4[CH:34]=[CH:35][CH:36]=[CH:37][C:24]3=4)[CH2:19]2)=[CH:13][CH:14]=1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
3.0 ml of 2 M hydrochloric acid/ethyl ether was added to a solution of (R)-5,11-dihydro-5-[1-[3-(4-methoxyphenyl)propyl]pyrrolidine-3-yl]dibenzo[b,e][1,4]oxazepine (78 mg, 0.19 mmol) in dichloromethane, and they were stirred for 1 hour. The solvent was evaporated under reduced pressure to obtain the title compound in the form of a light yellow solid (73 mg, 86%).
後処理
- customThe solvent was evaporated under reduced pressure
出典と根拠
- ORDレコード
- ord-cd2dec55b2df4eef9ddc6d37f95b6e76
- 出典データセット
- uspto-grants-2003_03
- 特許番号
- US06528504B2
反応ノート
読み込み中…